251 related articles for article (PubMed ID: 22523431)
1. Fra-2 transgenic mice as a novel model of pulmonary hypertension associated with systemic sclerosis.
Maurer B; Reich N; Juengel A; Kriegsmann J; Gay RE; Schett G; Michel BA; Gay S; Distler JH; Distler O
Ann Rheum Dis; 2012 Aug; 71(8):1382-7. PubMed ID: 22523431
[TBL] [Abstract][Full Text] [Related]
2. The Fra-2 transgenic mouse model of systemic sclerosis.
Maurer B; Distler JH; Distler O
Vascul Pharmacol; 2013 Mar; 58(3):194-201. PubMed ID: 23232070
[TBL] [Abstract][Full Text] [Related]
3. Role of Stromelysin 2 (Matrix Metalloproteinase 10) as a Novel Mediator of Vascular Remodeling Underlying Pulmonary Hypertension Associated With Systemic Sclerosis.
Avouac J; Guignabert C; Hoffmann-Vold AM; Ruiz B; Dorfmuller P; Pezet S; Amar O; Tu L; Van Wassenhove J; Sadoine J; Launay D; Elhai M; Cauvet A; Subramaniam A; Resnick R; Hachulla E; Molberg Ø; Kahan A; Humbert M; Allanore Y
Arthritis Rheumatol; 2017 Nov; 69(11):2209-2221. PubMed ID: 28805015
[TBL] [Abstract][Full Text] [Related]
4. Nintedanib inhibits macrophage activation and ameliorates vascular and fibrotic manifestations in the Fra2 mouse model of systemic sclerosis.
Huang J; Maier C; Zhang Y; Soare A; Dees C; Beyer C; Harre U; Chen CW; Distler O; Schett G; Wollin L; Distler JHW
Ann Rheum Dis; 2017 Nov; 76(11):1941-1948. PubMed ID: 28814429
[TBL] [Abstract][Full Text] [Related]
5. Transcription factor fos-related antigen-2 induces progressive peripheral vasculopathy in mice closely resembling human systemic sclerosis.
Maurer B; Busch N; Jüngel A; Pileckyte M; Gay RE; Michel BA; Schett G; Gay S; Distler J; Distler O
Circulation; 2009 Dec; 120(23):2367-76. PubMed ID: 19933934
[TBL] [Abstract][Full Text] [Related]
6. Pan-PPAR agonist IVA337 is effective in experimental lung fibrosis and pulmonary hypertension.
Avouac J; Konstantinova I; Guignabert C; Pezet S; Sadoine J; Guilbert T; Cauvet A; Tu L; Luccarini JM; Junien JL; Broqua P; Allanore Y
Ann Rheum Dis; 2017 Nov; 76(11):1931-1940. PubMed ID: 28801346
[TBL] [Abstract][Full Text] [Related]
7. Levels of target activation predict antifibrotic responses to tyrosine kinase inhibitors.
Maurer B; Distler A; Dees C; Khan K; Denton CP; Abraham D; Gay RE; Michel BA; Gay S; Hw Distler J; Distler O
Ann Rheum Dis; 2013 Dec; 72(12):2039-46. PubMed ID: 24013728
[TBL] [Abstract][Full Text] [Related]
8. The transcription factor Fra-2 regulates the production of extracellular matrix in systemic sclerosis.
Reich N; Maurer B; Akhmetshina A; Venalis P; Dees C; Zerr P; Palumbo K; Zwerina J; Nevskaya T; Gay S; Distler O; Schett G; Distler JH
Arthritis Rheum; 2010 Jan; 62(1):280-90. PubMed ID: 20039427
[TBL] [Abstract][Full Text] [Related]
9. Transcription factor Fra-2 and its emerging role in matrix deposition, proliferation and inflammation in chronic lung diseases.
Birnhuber A; Biasin V; Schnoegl D; Marsh LM; Kwapiszewska G
Cell Signal; 2019 Dec; 64():109408. PubMed ID: 31473307
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-β plays divergent roles in modulating vascular remodeling, inflammation, and pulmonary fibrosis in a murine model of scleroderma.
Tsujino K; Reed NI; Atakilit A; Ren X; Sheppard D
Am J Physiol Lung Cell Mol Physiol; 2017 Jan; 312(1):L22-L31. PubMed ID: 27864286
[TBL] [Abstract][Full Text] [Related]
11. Meprin β, a novel mediator of vascular remodelling underlying pulmonary hypertension.
Biasin V; Marsh LM; Egemnazarov B; Wilhelm J; Ghanim B; Klepetko W; Wygrecka M; Olschewski H; Eferl R; Olschewski A; Kwapiszewska G
J Pathol; 2014 May; 233(1):7-17. PubMed ID: 24258247
[TBL] [Abstract][Full Text] [Related]
12. Cardiomyopathy in murine models of systemic sclerosis.
Venalis P; Kumánovics G; Schulze-Koops H; Distler A; Dees C; Zerr P; Palumbo-Zerr K; Czirják L; Mackevic Z; Lundberg IE; Distler O; Schett G; Distler JH
Arthritis Rheumatol; 2015 Feb; 67(2):508-16. PubMed ID: 25371068
[TBL] [Abstract][Full Text] [Related]
13. Pirfenidone exacerbates Th2-driven vasculopathy in a mouse model of systemic sclerosis-associated interstitial lung disease.
Birnhuber A; Jandl K; Biasin V; Fließer E; Valzano F; Marsh LM; Krolczik C; Olschewski A; Wilhelm J; Toller W; Heinemann A; Olschewski H; Wygrecka M; Kwapiszewska G
Eur Respir J; 2022 Oct; 60(4):. PubMed ID: 35332068
[TBL] [Abstract][Full Text] [Related]
14. Platelet-derived growth factor receptor-β and epidermal growth factor receptor in pulmonary vasculature of systemic sclerosis-associated pulmonary arterial hypertension versus idiopathic pulmonary arterial hypertension and pulmonary veno-occlusive disease: a case-control study.
Overbeek MJ; Boonstra A; Voskuyl AE; Vonk MC; Vonk-Noordegraaf A; van Berkel MP; Mooi WJ; Dijkmans BA; Hondema LS; Smit EF; Grünberg K
Arthritis Res Ther; 2011 Apr; 13(2):R61. PubMed ID: 21492463
[TBL] [Abstract][Full Text] [Related]
15. Acazicolcept (ALPN-101), a dual ICOS/CD28 antagonist, demonstrates efficacy in systemic sclerosis preclinical mouse models.
Orvain C; Cauvet A; Prudent A; Guignabert C; Thuillet R; Ottaviani M; Tu L; Duhalde F; Nicco C; Batteux F; Avouac J; Wang N; Seaberg MA; Dillon SR; Allanore Y
Arthritis Res Ther; 2022 Jan; 24(1):13. PubMed ID: 34986869
[TBL] [Abstract][Full Text] [Related]
16. Recombinant Adenosine Deaminase Ameliorates Inflammation, Vascular Disease, and Fibrosis in Preclinical Models of Systemic Sclerosis.
Zhang Y; Zhu H; Layritz F; Luo H; Wohlfahrt T; Chen CW; Soare A; Bergmann C; Ramming A; Groeber F; Reuter C; Fornasini G; Soukhareva N; Schreiber B; Ramamurthy S; Amann K; Schett G; Distler JHW
Arthritis Rheumatol; 2020 Aug; 72(8):1385-1395. PubMed ID: 32182396
[TBL] [Abstract][Full Text] [Related]
17. Impaired bone morphogenetic protein receptor II signaling in a transforming growth factor-β-dependent mouse model of pulmonary hypertension and in systemic sclerosis.
Gilbane AJ; Derrett-Smith E; Trinder SL; Good RB; Pearce A; Denton CP; Holmes AM
Am J Respir Crit Care Med; 2015 Mar; 191(6):665-77. PubMed ID: 25606692
[TBL] [Abstract][Full Text] [Related]
18. IL-1 receptor blockade skews inflammation towards Th2 in a mouse model of systemic sclerosis.
Birnhuber A; Crnkovic S; Biasin V; Marsh LM; Odler B; Sahu-Osen A; Stacher-Priehse E; Brcic L; Schneider F; Cikes N; Ghanim B; Klepetko W; Graninger W; Allanore Y; Eferl R; Olschewski A; Olschewski H; Kwapiszewska G
Eur Respir J; 2019 Sep; 54(3):. PubMed ID: 31320452
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary fibrosis in Fra-2 transgenic mice is associated with decreased numbers of alveolar macrophages and increased susceptibility to pneumococcal pneumonia.
Tabeling C; Wienhold SM; Birnhuber A; Brack MC; Nouailles G; Kershaw O; Firsching TC; Gruber AD; Lienau J; Marsh LM; Olschewski A; Kwapiszewska G; Witzenrath M
Am J Physiol Lung Cell Mol Physiol; 2021 May; 320(5):L916-L925. PubMed ID: 33655757
[TBL] [Abstract][Full Text] [Related]
20. Endothelial injury in a transforming growth factor β-dependent mouse model of scleroderma induces pulmonary arterial hypertension.
Derrett-Smith EC; Dooley A; Gilbane AJ; Trinder SL; Khan K; Baliga R; Holmes AM; Hobbs AJ; Abraham D; Denton CP
Arthritis Rheum; 2013 Nov; 65(11):2928-39. PubMed ID: 23839959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
